Skip to Content

Nike Inc Class B

NKE: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$623.00BhnfZfncwpmrhb

Nike Earnings: Dim Sales Outlook Slams Shares but Patient Investors Could Be Rewarded

Nike’s shares roughly doubled their year-to-date decline with a 12% tumble in June 27 aftermarket trading as persistent sales weakness has added uncertainty to the firm's turnaround. Although the firm had warned of a difficult demand environment for sportswear and we had lowered our estimates, market conditions are more challenging than expected. Specifically, after posting flat sales growth in (May-ended) fiscal 2024, Nike guided to a mid-single-digit percentage sales decline for fiscal 2025. Given that we had projected 1% sales growth, we expect to reduce our fair value estimate of $129 per share by a low-single-digit percentage. Even so, we regard the share price weakness as an opportunity for long-term investors, given that the wide-moat sportswear leader stands to benefit over the next few years from its planned marketing and product initiatives and the growth of the global market.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of NKE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center